News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News AHA 2016 Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement Shelley Wood November 14, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Conference News TCT 2016 Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients Todd Neale November 02, 2016
News Industry News TCT 2016 Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement November 01, 2016
News Daily News ICD and Pacemaker Needs After Open Heart Surgery: Series Provides a Benchmark Todd Neale October 21, 2016
News Industry News Medtronic Avalus(TM) Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results October 04, 2016
News Daily News New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk Todd Neale September 29, 2016
News Conference News PCR London Valves 2016 TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients Shelley Wood September 20, 2016
News Daily News Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe Michael O'Riordan September 20, 2016
News Conference News PCR London Valves 2016 Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies Shelley Wood September 19, 2016
News Industry News Boston Scientific Receives CE Mark For LOTUS Edge™ Valve System September 19, 2016
News Daily News Elderly Asymptomatic Patients With Severe AS Are Often Treated Too Late L.A. McKeown September 16, 2016
News Daily News La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro Yael L. Maxwell September 14, 2016
News Daily News TAVR as an Option for Intermediate-Risk Patients: Physicians Respond Yael L. Maxwell August 24, 2016
News Daily News FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients Yael L. Maxwell August 18, 2016
News Industry News EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval August 15, 2016
News Daily News CMR Confirms Link Between Moderate Aortic Regurgitation Post-TAVR and Poor Outcomes, Mortality Yael L. Maxwell August 05, 2016
News Daily News Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients Todd Neale August 01, 2016